Low molecular weight heparin aggravates infectious arthritis triggered by Staphylococcus aureus

Journal of Orthopaedic Research

Volumn 20, Issue 2, 2002, Pages 198-203

  Sakiniene, Egidija ^a   Tarkowski, Andrzej ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Arthritis; Heparin; S. aureus

Indexed keywords

BACTERIA; DISEASES; GRAFTS; IMPLANTS (SURGICAL); MOLECULAR WEIGHT;

WOUND INFECTIONS;

ORTHOPEDICS;

DALTEPARIN; LOW MOLECULAR WEIGHT HEPARIN; TOXIC SHOCK SYNDROME TOXIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL ARTHRITIS; BACTERIAL STRAIN; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; ENDOPROSTHESIS; HISTOPATHOLOGY; IMPLANTATION; INFECTIOUS ARTHRITIS; INFLAMMATION; INOCULATION; JOINT DESTRUCTION; JOINT SURGERY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; SURGICAL TECHNIQUE; T LYMPHOCYTE; THROMBOSIS; WOUND INFECTION;

ANIMALS; ARTHRITIS, INFECTIOUS; DISEASE MODELS, ANIMAL; HEPARIN, LOW-MOLECULAR-WEIGHT; HYPERSENSITIVITY, DELAYED; JOINTS; MALE; MICE; MICE, INBRED STRAINS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SYNOVITIS; T-LYMPHOCYTES;

EID: 0036118356     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-0266(01)00085-7     Document Type: Article

References (36)

1. The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model
2. Clonal expansion of T lymphocytes causes arthritis and mortality in mice infected with toxic shock syndrome toxin-1 producing staphylococci
3. Role of T lymphocytes in experimental Staphylococcus aureus arthritis
4. Prosthetic osteomyelitis with special reference to the knee: Risks, treatment and costs
5. Multiple binding sites in fibronectin and staphylococcal fibronectin receptor
6. Immunopathological features of rat Staphylococcus aureus arthritis
7. Outbreak of spontaneous staphylococcal arthritis and osteitis in mice
8. Experimental Staphylococcus aureus arthritis in mice
9. Oestradiol and testosterone-mediated effects on the immune system in normal and autoimmune mice are genetically linked and inherited as dominant traits
10. Anti-inflammatory effects of heparin and its derivatives. Inhibition of complement and of lymphocyte migration
11. Bacterial arthritis
12. Synovial membrane histopathology in the different diagnosis of rheumatoid arthritis, gout, pseudogout, systemic lupus erythematosus, infectious arthritis and degenerative joint disease
13. Rational antithrombotic therapy and prophylaxis in elderly, immobile patients
14. Heparin binding protein (CAP37) is an opsonin for Staphylococcus aureus and increases phagocytosis in monocytes
15. The DTH-initiating Thy-1+ cell is double-negative (CD4-, CD8-) and CD3-, and expresses IL-3 receptors, but no IL-2 receptors
16. TNF/lymphotoxin-alpha double-mutant mice resist septic arthritis but display increased mortality in response to Staphylococcus aureus
17. Risk factors for septic arthritis in patients with joint diseasea. A prospective study
18. Fibronectin as a co-factor necessary for optimal granulocyte phagocytosis of Staphylococcus aureus
19. Inhibition of T lymphocyte heparanase by heparin prevents T cell migration and T cell-mediated immunity
20. Homogenous, structurally defined heparin-oligosaccharides with low anticoagulant activity inhibit the generation of the amplification pathway C3 convertase in vitro
21. Neutralization of the cytolytic and myotoxic activities of phospholipases A2 from Bothrops asper snake venom by glycosaminoglycans of the heparin/heparan sulfate family
22. Surgical bacteremia. Analysis of 210 episodes with special attention to factors influencing prognosis
23. Methicillin-resistant staphylococci in clean surgery. Is there a role for prophylaxis
24. Highlights in the history of heparin
25. Inhibition of nitric oxide synthase aggravates Staphylococcus aureus septicemia and septic arthritis
26. Complement depletion aggravates Staphylococcus aureus septicemia and septic arthritis
27. Inhibitory effect of heparin on neutrophil phagocytosis and burst production using a new whole-blood cytofluorometric method for determination
28. Thromboembolic complications after arthroscopic knee surgery. Incidence and risk factors in 101 patients
29. Staphylococcus aureus. The persistant pathogen
30. Inhibition of delayed-type hypersensitivity by heparin depleted of antocoagulant activity
31. Inhibition by heparin and derivatized dextrans of Staphylococcus aureus adhesion to fibronectin-coated biomaterials
32. Role of neutrophils in experimental septicemia and septic arthritis induced by Staphylococcus aureus
33. Expression of heparanase by platelets and circulating cells of the immune system: Possible involvement in diapedesis and extravasation
34. Heparin and modified heparin inhibit complement activation in vivo
35. Six years of surgical wound infection surveillance at a tertiary care center: Review of the microbiologic and epidemiological aspects of 20007 wounds
36. Mice with the Xid B cell defect are less susceptible to developing Staphylococcus aureus induced arthritis